Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney Davis

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Social Science & Medicine (1982)|January 22, 2015
Clarity, constructive debate and progress in developing methodological and conceptual frameworks for understanding pharmaceuticalization: a reply to AbrahamCourtney Davis
Social Science & Medicine (1982)|December 24, 2014
Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?Courtney Davis
Sociology of Health & Illness|February 15, 2011
Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulationCourtney Davis, John Abraham
Social History of Medicine : the Journal of the Society for the Social History of Medicine|December 13, 2006
Testing times: the emergence of the practolol disaster and its challenge to British drug regulation in the modern periodJohn Abraham, Courtney Davis
Health Research Policy and Systems|November 11, 2017
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviewsShai Mulinari, Courtney Davis
BMJ (Clinical Research Ed.)|March 12, 2020
Inappropriate use of progression-free survival in cancer drug approvalsHuseyin Naci, Courtney Davis
Social Science & Medicine (1982)|June 16, 2005
A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policyJohn Abraham, Courtney Davis
Social Studies of Science|November 20, 2019
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug RelenzaShai Mulinari, Courtney Davis
Social Studies of Science|October 24, 2009
Drug evaluation and the permissive principle: continuities and contradictions between standards and practices in antidepressant regulationJohn Abraham, Courtney Davis
BMC Medical Education|June 16, 2026
The use of adolescent standardized patients to teach psychosocial risk assessment and its impact on medical student self‑efficacyCourtney Davis, Kumudhini Rajasegaran
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Social Science & Medicine (1982)|January 22, 2015
Clarity, constructive debate and progress in developing methodological and conceptual frameworks for understanding pharmaceuticalization: a reply to AbrahamCourtney Davis
Social Science & Medicine (1982)|December 24, 2014
Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?Courtney Davis
Sociology of Health & Illness|February 15, 2011
Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulationCourtney Davis, John Abraham
Social History of Medicine : the Journal of the Society for the Social History of Medicine|December 13, 2006
Testing times: the emergence of the practolol disaster and its challenge to British drug regulation in the modern periodJohn Abraham, Courtney Davis
Health Research Policy and Systems|November 11, 2017
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviewsShai Mulinari, Courtney Davis
BMJ (Clinical Research Ed.)|March 12, 2020
Inappropriate use of progression-free survival in cancer drug approvalsHuseyin Naci, Courtney Davis
Social Science & Medicine (1982)|June 16, 2005
A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policyJohn Abraham, Courtney Davis
Social Studies of Science|November 20, 2019
The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug RelenzaShai Mulinari, Courtney Davis
Social Studies of Science|October 24, 2009
Drug evaluation and the permissive principle: continuities and contradictions between standards and practices in antidepressant regulationJohn Abraham, Courtney Davis
BMC Medical Education|June 16, 2026
The use of adolescent standardized patients to teach psychosocial risk assessment and its impact on medical student self‑efficacyCourtney Davis, Kumudhini Rajasegaran
Pageof 7